1. Home
  2. BIVI vs MOBX Comparison

BIVI vs MOBX Comparison

Compare BIVI & MOBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIVI
  • MOBX
  • Stock Information
  • Founded
  • BIVI 2013
  • MOBX 2020
  • Country
  • BIVI United States
  • MOBX United States
  • Employees
  • BIVI 14
  • MOBX N/A
  • Industry
  • BIVI Biotechnology: Pharmaceutical Preparations
  • MOBX
  • Sector
  • BIVI Health Care
  • MOBX
  • Exchange
  • BIVI Nasdaq
  • MOBX Nasdaq
  • Market Cap
  • BIVI 18.8M
  • MOBX 46.9M
  • IPO Year
  • BIVI N/A
  • MOBX N/A
  • Fundamental
  • Price
  • BIVI $1.02
  • MOBX $0.98
  • Analyst Decision
  • BIVI Strong Buy
  • MOBX
  • Analyst Count
  • BIVI 1
  • MOBX 0
  • Target Price
  • BIVI $30.00
  • MOBX N/A
  • AVG Volume (30 Days)
  • BIVI 297.1K
  • MOBX 241.1K
  • Earning Date
  • BIVI 05-13-2025
  • MOBX 02-18-2025
  • Dividend Yield
  • BIVI N/A
  • MOBX N/A
  • EPS Growth
  • BIVI N/A
  • MOBX N/A
  • EPS
  • BIVI N/A
  • MOBX N/A
  • Revenue
  • BIVI N/A
  • MOBX $9,326,000.00
  • Revenue This Year
  • BIVI N/A
  • MOBX N/A
  • Revenue Next Year
  • BIVI N/A
  • MOBX N/A
  • P/E Ratio
  • BIVI N/A
  • MOBX N/A
  • Revenue Growth
  • BIVI N/A
  • MOBX 1023.61
  • 52 Week Low
  • BIVI $0.99
  • MOBX $0.55
  • 52 Week High
  • BIVI $7.50
  • MOBX $3.62
  • Technical
  • Relative Strength Index (RSI)
  • BIVI 23.10
  • MOBX 37.33
  • Support Level
  • BIVI $1.09
  • MOBX $0.94
  • Resistance Level
  • BIVI $1.24
  • MOBX $1.10
  • Average True Range (ATR)
  • BIVI 0.10
  • MOBX 0.10
  • MACD
  • BIVI -0.01
  • MOBX -0.01
  • Stochastic Oscillator
  • BIVI 6.67
  • MOBX 12.94

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

About MOBX Mobix Labs Inc.

Mobix Labs Inc. specializes in designing, developing, and selling components and systems for wireless and wired connectivity, radio frequency (RF) technologies, switching, and electromagnetic interference (EMI) filtering solutions. The company serves markets, including commercial, industrial, automotive, medical, aerospace, defense, and others.

Share on Social Networks: